The IDEAL Trial - a Study Protocol for a Phase III Randomized, Double-Blinded Clinical Trial Assessing the Ultra-Short Antibiotic Prophylaxis of Isoniazid and Rifapentine in Non-Immunosuppressed Patients With Newly Diagnosed Latent Tuberculosis. PPCR 2020, 6 (1), 9-14.